Click to goto CDHA Public Site Click to goto DivEMS Dal Public Site Click to goto EHS Nova Scotia

Violent-Agitated

Date Last Search Run: Sep 12, 2023

Data last added: Jul 18, 2023

Recommendation RECOMMENDATION FOR INTERVENTION
STRENGTH OF EVIDENCE FOR INTERVENTION   SUPPORTIVE (Green) NEUTRAL (Yellow) AGAINST (Red) NOT YET GRADED (White)
1 (strong evidence exists)        
2 (fair evidence exists)    
3 (weak evidence exists)    


Interventions

Antipsychotics
Level Direction Primary Outcome Patient/Process Setting Reference
III Supportive (Green) Efficacy and Safety Patient ED-MD Ramsden SC, Pergjika A, Janssen AC, Mudahar S, Fawcett A, Walkup JT, Hoffmann JA. A systematic review of the effectiveness and safety of droperidol for pediatric agitation in acute care settings. Acad Emerg Med 2022. Medline

Benzodiazepines
Level Direction Primary Outcome Patient/Process Setting Reference
II Supportive (Green) Improvement Patient PH-Paramedic Sandoval S, Goyal A, Frawley J, et al. Prehospital Use of Ketamine versus Benzodiazepines for Sedation among Pediatric Patients with Behavioral Emergencies. Prehosp Emerg Care 2023;1-7. Medline

Ketamine
Level Direction Primary Outcome Patient/Process Setting Reference
II Supportive (Green) Safety Patient PH-Paramedic Goyal A, Frawley J, Gappy R, Sandoval S, Chen NW, Crowe R, Swor R. Prehospital Ketamine Use in Pediatrics. Prehosp Emerg Care 2022; 1–11 Medline
II Supportive (Green) Improvement Patient PH-Paramedic Sandoval S, Goyal A, Frawley J, et al. Prehospital Use of Ketamine versus Benzodiazepines for Sedation among Pediatric Patients with Behavioral Emergencies. Prehosp Emerg Care 2023;1-7. Medline


[ PEP Database - Table of Contents ] [ Email: PEP@Dal.ca ]